Total Funding
80
53
Total FundingVenture - Series Unknown raised
Growth Score
-9 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
991742
GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs.
Acquired by 
Genzyme
George Whitesides: Co-FounderPast Role: Massachusetts Institute of Technology, Faculty Member
About the Company
GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs that bind and eliminate targeted substances within the gastrointestinal tract. It also develops small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators. Its focus areas include hyperphosphatemia, hypercholesterolemia, cancer, iron overload, and
infectious diseases.
GelTex Pharmaceutics is based in Waltham Massachusetts.
